While several different WAS and XLT-causing mutations were identified [15], most of them map to the binding site for WASp-interacting protein (WIP), and some of them were shown to disrupt the interaction of these proteins, thereby promoting WASp degradation [16]. This evidence concerns the gene WIPF1 and thrombocytopenia 1.